¹⁸ F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial.

Autor: Cooke SA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands. Electronic address: s.cooke@nki.nl., de Ruysscher D; Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Reymen B; Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Lambrecht M; Department of Oncology, Experimental Radiation Oncology, KU Leuven - University of Leuven, Leuven, Belgium; Department of Radiotherapy-Oncology, University Hospitals Leuven, Gasthuisberg, Belgium., Fredberg Persson G; Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Faivre-Finn C; Department of Clinical Oncology, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK., Dieleman EMT; Department of Radiation Oncology, location AMC, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Lewensohn R; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; Theme Cancer, Section of Head, Neck, Lung and Skin Tumours, Karolinska University Hospital, Stockholm, Sweden., van Diessen JNA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Sikorska K; Department of Biometrics, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Lalezari F; Department of Radiology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Vogel W; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands; Department of Nuclear Medicine, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., van Elmpt W; Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Damen EMF; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Sonke JJ; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Belderbos JSA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands. Electronic address: J.belderbos@nki.nl.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Apr; Vol. 181, pp. 109492. Date of Electronic Publication: 2023 Jan 24.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.